Takeda teams up with Koneksa to integrate remote data capture into clinical trials

Courtesy of Koneksa Health

Takeda is enlisting data integration player Koneksa Health on a scheme to bring new digital health tools to its clinical trials. The partnership will see Takeda using Koneksa’s remote data collection capabilities in trials for multiple pipeline candidates.

The goal of the tie-up is to develop “digital biomarkers” that could support decision-making and eventually contribute to new endpoints that will improve the assessment of patients in their natural environment, according to a statement.

The Japanese pharma will use Koneksa’s platform to integrate biosensors and wearables in a number of early-stage clinical trials, according to the statement. The technology facilitates the collection of patient-generated data that were previously tricky to obtain, such as patients’ continuous vital signs, activity levels and sleep metrics, Takeda said.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

“Working with Koneksa enables us to take advantage of technologies and expertise that provide access to novel data streams and make our clinical trials more patient-centric,” said Elena Izmailova, senior director of novel data streams and devices at Takeda, in the statement. “Koneksa’s end-to-end solution allows us to collect this data in our studies using Koneksa’s sensors and devices.”

“Wearable technology and remote, electronic patient data capture are valuable tools for fortifying research with a sound foundational framework,” the companies said. And while there is a slew of apps, mobile apps and clinical in-home devices that remotely collect patient data, the integration of these data for caregivers and researchers is a work in progress. Aside from Koneksa, Validic has embarked on multiple partnerships to work on data integration. And last month, the digital health company teamed up with Sutter Health to investigate how best to deliver patient-generated data for clinicians and researchers.

Suggested Articles

Novocure’s tumor-treating electric field system scored an FDA nod in mesothelioma, making it the first new treatment in more than 15 years.

FLX Bio is renaming itself RAPT Therapeutics to reflect its expansion into allergy and inflammatory diseases.

The preclinical-stage biotech wants the cash to take an antisense oligonucleotide treatment for Dravet syndrome through to phase 3.